founded in 1949, stevanato group is committed to create systems, processes and services that guarantee the integrity of parenteral medicines. it is comprised of two operational divisions: - pharmaceutical systems (ompi and balda brands): specialized in ready-to-use glass containers and bulk primary packaging (syringes, cartridges, vials and ampoules); high quality and high precision plastic solutions for diagnostic, pharmaceutical and medical device applications. - engineering systems (spami, optrel, innoscan and svm brands): specialized in glass forming technology, inspection systems, assembly, packaging machines and serialization solutions for the pharmaceutical industry. these two divisions enjoy a close, synchronous relationship, featuring daily exchanges which ensure that stevanato group has complete control over the entire production process, from purchasing the finest raw materials to offering exceptional after-sales customer service. the group also benefits from the sglab activ
Company profile
Ticker
STVN
Exchange
Website
CEO
Franco Moro
Employees
Location
Industry (SIC)
SEC CIK
STVN stock data
Latest filings (excl ownership)
6-K
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares
26 Mar 24
6-K
Current report (foreign)
26 Mar 24
6-K
Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
25 Mar 24
424B5
Prospectus supplement for primary offering
25 Mar 24
6-K
Stevanato Group Announces Public Offering of Ordinary Shares
20 Mar 24
424B5
Prospectus supplement for primary offering
20 Mar 24
F-3ASR
Automatic shelf registration (foreign)
20 Mar 24
6-K
Current report (foreign)
15 Mar 24
20-F
2023 FY
Annual report (foreign)
7 Mar 24
6-K
Current report (foreign)
7 Mar 24
Transcripts
STVN
Earnings call transcript
2023 Q4
7 Mar 24
STVN
Earnings call transcript
2023 Q3
31 Oct 23
STVN
Earnings call transcript
2023 Q2
28 Jul 23
STVN
Earnings call transcript
2022 Q4
2 Mar 23
STVN
Earnings call transcript
2022 Q2
6 Aug 22
STVN
Earnings call transcript
2021 Q4
8 Mar 22
STVN
Earnings call transcript
2021 Q2
19 Aug 21
Latest ownership filings
SC 13G/A
LAZARD ASSET MANAGEMENT LLC
15 Feb 24
SC 13G/A
AMERIPRISE FINANCIAL INC
14 Feb 24
SC 13G
SANDS CAPITAL MANAGEMENT, LLC
13 Feb 24
SC 13G
Neuberger Berman Group LLC
12 Feb 24
SC 13G
Copeland Capital Management, LLC
22 Jan 24
SC 13G/A
Conestoga Capital Advisors, LLC
5 Jan 24
144/A
Notice of proposed sale of securities (amended)
14 Jun 23
144
Notice of proposed sale of securities
14 Jun 23
SC 13G/A
LAZARD ASSET MANAGEMENT LLC
8 Mar 23
SC 13G/A
NORGES BANK
14 Feb 23
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Institutional ownership, Q4 2022
88.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 107 |
Opened positions | 31 |
Closed positions | 7 |
Increased positions | 36 |
Reduced positions | 29 |
13F shares | Current |
---|---|
Total value | 416.29 bn |
Total shares | 262.81 mm |
Total puts | 200.00 |
Total calls | 11.00 k |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
Stevanato Holding S.r.l. | 230.60 mm | $5.18 bn |
Lazard Asset Management | 4.46 mm | $80.22 mm |
Conestoga Capital Advisors | 3.47 mm | $62.38 bn |
Copeland Capital Management | 2.12 mm | $38.10 mm |
AMP Ameriprise Financial | 2.02 mm | $36.23 bn |
Clearbridge Advisors | 1.64 mm | $29.45 bn |
GS Goldman Sachs | 1.22 mm | $21.83 bn |
Wellington Management | 1.10 mm | $19.78 bn |
Millennium Management | 1.03 mm | $18.65 bn |
ArrowMark Colorado | 942.56 k | $16.94 bn |
News
Stephens & Co. Reiterates Overweight on Stevanato Gr, Maintains $38 Price Target
25 Mar 24
Stevanato Group Prices Upsized Public Offering Of 12.7M Ordinary Shares At $26/Share
22 Mar 24
Stevanato Group Reports Launch Of Public Offering Of An Aggregate Of $300M Of Its Ordinary Shares
20 Mar 24
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
7 Mar 24
Stevanato Gr Q4 2023 Adj EPS $0.194 Beats $0.190 Estimate, Sales $345.091M Beat $326.434M Estimate
7 Mar 24
Press releases
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters' Option to Purchase Additional Ordinary Shares
26 Mar 24
Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
21 Mar 24
Stevanato Group Announces Public Offering of Ordinary Shares
20 Mar 24
Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
11 Mar 24
Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023
7 Mar 24